Bank of America’s Aerie Pharmaceuticals AERI Stock Holding History

Bank of America’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20,000	Closed	-$722K	–	7523
2018 Q4	$722K	Hold	20,000	–	–	﹤0.01%	4665
2018 Q3	$1.23M	Hold	20,000	–	–	﹤0.01%	4349
2018 Q2	$1.35M	Hold	20,000	–	–	﹤0.01%	4272
2018 Q1	$1.08M	Hold	20,000	–	–	﹤0.01%	4327
2017 Q4	$1.2M	Hold	20,000	–	–	﹤0.01%	4365
2017 Q3	$972K	Buy	+20,000	New	+$1.09M	﹤0.01%	4525

Bank of America's AERI Position: Q4 2022 in Review

Bank of America sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 1,081,133 shares — an estimated $16.4M sold.

Bank of America first reported a position in AERI in Q4 2013 and held it in 35 quarters. The position peaked at $47.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Bank of America reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Bank of America sold 1,081,133 Aerie Pharmaceuticals shares in Q4 2022, an estimated $16.4M.
Bank of America first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 35 quarters.
Bank of America's Aerie Pharmaceuticals position peaked at $47.5M in Q1 2021.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.